Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People between the ages of 35 and 92 at the time of joining the trial.
- People who have been diagnosed with idiopathic Parkinson's disease (Parkinson's with no known cause) at a mid-range stage of the condition, based on a standard medical scale called Hoehn and Yahr stages 2 to 4 (confirm with trial site for the upper end of this range).
- People who are fluent in English.
- People who are comfortable using a computer, checking email, browsing the internet, and taking part in video calls for training and check-ins.
- People who are comfortable temporarily stopping their Parkinson's-related medication during in-person study visits.
- People who currently live in the United States.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with significant mental health or brain-related conditions, such as acute confusion, active psychosis, or suicidal thoughts.
- People who are currently misusing drugs or alcohol.
- People who are currently taking part in, or have taken part in, another clinical trial involving a drug, device, or biological treatment within the past 30 days (any exceptions would need to be approved by the trial's lead researchers).
- People who are pregnant, breastfeeding, or planning to become pregnant.
- People who have previously had a craniotomy (a type of brain surgery where part of the skull is opened).
- People who have previously had any brain surgery.
- People who have severe difficulty speaking that would prevent them from communicating clearly with the study staff.
- People who experience excessive drooling.
- People who are currently taking a medication that may cause significant withdrawal effects if stopped.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
If you need support right now
This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.
If you or someone else is in immediate danger, call 000.
- Lifeline — 24/7 crisis support: 13 11 14
- Suicide Call Back Service — 24/7 counselling: 1300 659 467
- 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
- Beyond Blue — 24/7 mental health support: 1300 22 4636
- Emergency: 000
Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.
Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.
Contact this trial
Principal Investigator: Peter A Tass, MD, PhD, Stanford University
Phone: 6504749547
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Parkinsonian symptoms as defined by the change in Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.